- Report
- February 2023
- 175 Pages
Global
From €4513EUR$5,000USD£3,912GBP
- Report
- July 2024
- 80 Pages
Japan
From €3159EUR$3,500USD£2,739GBP
- Report
- May 2026
- 185 Pages
Global
From €4061EUR$4,500USD£3,521GBP
- Report
- May 2026
- 185 Pages
Global
From €4061EUR$4,500USD£3,521GBP
- Report
- May 2026
- 192 Pages
Global
From €4061EUR$4,500USD£3,521GBP
- Report
- June 2025
- 180 Pages
Global
From €4061EUR$4,500USD£3,521GBP
- Report
- January 2025
- 140 Pages
Asia Pacific
From €3610EUR$4,000USD£3,130GBP
- Report
- December 2024
- 87 Pages
Spain
From €3159EUR$3,500USD£2,739GBP
- Report
- May 2024
- 182 Pages
Global
From €4061EUR$4,500USD£3,521GBP
- Report
- November 2023
- 78 Pages
France
From €3159EUR$3,500USD£2,739GBP
- Report
- November 2023
- 78 Pages
Germany
From €3159EUR$3,500USD£2,739GBP
- Report
- November 2023
- 83 Pages
Germany
From €3159EUR$3,500USD£2,739GBP
- Report
- October 2023
- 73 Pages
Canada
From €3159EUR$3,500USD£2,739GBP
- Report
- November 2023
- 77 Pages
France
From €3159EUR$3,500USD£2,739GBP
- Report
- February 2024
- 75 Pages
Global
From €4468EUR$4,950USD£3,873GBP
- Report
- October 2022
- 68 Pages
Global
- Report
- November 2021
- 106 Pages
Global
From €4468EUR$4,950USD£3,873GBP
- Report
- July 2024
- 150 Pages
Global
From €3385EUR$3,750USD£2,934GBP
- Report
- July 2024
- 100 Pages
Global
From €3385EUR$3,750USD£2,934GBP
- Report
- May 2026
- 182 Pages
Global
From €4061EUR$4,500USD£3,521GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more